Brazilian Journal of Psychiatry (Jul 2023)

A dopamine receptor D2 genetic polymorphism associated with transition to mental disorders in a cohort of individuals with at-risk mental state for psychosis

  • Julia Hatagami Marques,
  • Leda Leme Talib,
  • Lucas Hortêncio,
  • Julio Cesar Andrade,
  • Tania Maria Alves,
  • Mauricio Henriques Serpa,
  • Guilherme Lopes Yamamoto,
  • Martinus Theodorus van de Bilt,
  • Wulf Rössler,
  • Wagner Farid Gattaz,
  • Alexandre Andrade Loch

DOI
https://doi.org/10.47626/1516-4446-2023-3044
Journal volume & issue
Vol. 45, no. 3
pp. 268 – 273

Abstract

Read online Read online

Objectives: To test the association of 45 single nucleotide polymorphisms (SNPs) with transition to psychiatric disorders in a cohort of individuals at ultrahigh risk (UHR) mental state for psychosis. Methods: Through general population screening, 88 non-help-seeking UHR subjects and 130 healthy control individuals were genotyped for 45 SNPs related to psychosis. They were followed for a mean of 2.5 years, and conversion to psychotic and to general psychiatric disorders was assessed. Genotype frequencies between controls, converters, and non-converters were analyzed. Results: There were no differences in sociodemographics between controls and UHR. Also, UHR converters and non-converters had no differences in their baseline symptoms scores. The dopamine receptor D2 gene (DRD2) SNP rs6277 was significantly more common among UHR who transitioned to psychosis (p < 0.001) and to UHR who transitioned to any psychiatric disorders (p = 0.001) when compared to UHR who did not transition. The rs6277 T allele was related to psychiatric morbidity in a dose-response fashion, being significantly more frequent in UHR converters than UHR non-converters and control subjects (p = 0.003). Conclusion: Our findings suggest that rs6277 could potentially constitute a genetic marker of transition to psychiatric disorders in subjects with at-risk mental states, warranting further investigation in larger samples.

Keywords